Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.
Sonpavde G, Bellmunt J, Rosenberg JE, Regazzi AM, Bajorin DF, Choueiri TK, Qu AQ, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Fougeray R, Wong YN, Sridhar SS, Ko YJ, Milowsky MI, Galsky MD, Pond GR. Sonpavde G, et al. Clin Genitourin Cancer. 2014 Dec;12(6):395-8. doi: 10.1016/j.clgc.2014.03.016. Epub 2014 Jun 10. Clin Genitourin Cancer. 2014. PMID: 25035282 Review. No abstract available.
Systemic chemotherapy for urothelial cancer.
Sonpavde G, Hutson TE, Berry WR. Sonpavde G, et al. Clin Genitourin Cancer. 2006 Jun;5(1):34-42. doi: 10.3816/CGC.2006.n.015. Clin Genitourin Cancer. 2006. PMID: 16859577 Review.
Problems with the randomized discontinuation design.
Sonpavde G, Hutson TE, Galsky MD, Berry WR. Sonpavde G, et al. J Clin Oncol. 2006 Oct 1;24(28):4669-70; author reply 4670-1. doi: 10.1200/JCO.2006.08.1026. J Clin Oncol. 2006. PMID: 17008711 No abstract available.
Germ-cell tumors.
Kondagunta V, Galsky MD, Sonpavde G. Kondagunta V, et al. Among authors: sonpavde g. N Engl J Med. 2007 Oct 25;357(17):1773; author reply 1773-4. N Engl J Med. 2007. PMID: 17969229 No abstract available.
Novel agents for muscle-invasive and advanced urothelial cancer.
Sonpavde G, Ross R, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Lerner SP, Sternberg CN. Sonpavde G, et al. BJU Int. 2008 Apr;101(8):937-43. doi: 10.1111/j.1464-410X.2007.07326.x. Epub 2007 Nov 13. BJU Int. 2008. PMID: 18005203 Review.
502 results